Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PCRX | US
0.98
6.34%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
16.52
16.05
16.63
15.90
Pacira BioSciences Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL a bupivacaine liposome injectable suspension; ZILRETTA a triamcinolone acetonide extended-release injectable suspension; and iovera system a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals Inc. and changed its name to Pacira BioSciences Inc. in April 2019. Pacira BioSciences Inc. was incorporated in 2006 and is headquartered in Tampa Florida.
View LessValue Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
42.5%1 month
49.7%3 months
108.6%6 months
86.8%10.85
3.75
0.76
0.74
0.39
4.92
1.33
-3.83
175.34M
761.79M
761.79M
-
17.40
-24.50
5.00
7.54
4.66
18.15
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.85
Range1M
4.02
Range3M
12.84
Rel. volume
0.59
Price X volume
11.06M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 4.3 | 693.71M | 0.94% | 50.25 | -199.01% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 17.9 | 506.39M | -4.48% | n/a | 0.00% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 4.42 | 495.19M | 0.00% | n/a | 117.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.95 | 450.75M | 3.34% | n/a | -329.45% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.3933 | 420.15M | -6.31% | 19.50 | 0.00% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 3.08 | 408.33M | 8.07% | n/a | 42.12% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 2.12 | 331.23M | 1.44% | n/a | -471.04% |
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 5.5 | 301.75M | 2.42% | n/a | 0.00% |
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 6.04 | 267.99M | -0.33% | n/a | 0.27% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 4.92 | 262.25M | 2.71% | n/a | 39.24% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 4.92 | 17.21 | Cheaper |
Ent. to Revenue | 1.33 | 334.38 | Cheaper |
PE Ratio | 10.85 | 26.92 | Cheaper |
Price to Book | 0.76 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 108.63 | 68.34 | Riskier |
Debt to Equity | 0.74 | -1.00 | Expensive |
Debt to Assets | 0.39 | 0.48 | Par |
Market Cap | 761.79M | 5.31B | Emerging |